Clinitech Lab IPO

Clinitech Laboratory Ltd

₹1,15,200 /1200 sharesMinimum Investment

Clinitech Lab IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
25 Jul ‘24 - 29 Jul ‘24₹1,15,2001,200₹96 - ₹96
Issue SizeIPO Doc
5.78Cr
RHP PDF

About Clinitech Lab

Clinitech Laboratory Limited operates as a diagnostic and healthcare services provider with a network of eight diagnostic centres located in and around Thane and Navi Mumbai. The company conducts over three lakh tests annually. The company offers over 150 different tests. Clinitech categorises its services into several specialities, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology.;
Founded in
2010
Managing director
Mr. Jagdish Umakant Nayak
Parent organisation
Clinitech Laboratory Ltd

Strengths & Financials of Clinitech Lab

Strengths
Risks
The company has received a Certificate of Accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL) in line with ISO 15189:2012 standards, recognising the quality of its medical testing facilities.
With three decades of experience, Clinitech Laboratory has fostered enduring relationships with clients, leading to repeat business and opportunities to cross-sell other products and services.
Clinitech Laboratory collaborates with seven doctors who serve as consultants, overseeing the testing processes at its centres. These consultants supervise, analyse, and interpret test results before approving patient reports.
The company's operations are primarily focused in Thane and Navi Mumbai. A loss of business in these areas could significantly harm its overall business performance and financial health.
Clinitech Laboratory relies heavily on a small group of vendors for its supplies. In FY24, FY23, and FY22, purchases from the company’s top 10 vendors accounted for 81.07%, 79.76%, and 92.75% of total purchases, respectively, indicating a high dependency on these suppliers.
The company and its promoter directors are currently involved in legal proceedings. Any unfavourable judgments in these proceedings could lead to significant penalties, which could adversely affect the company's business.
The company has had negative cash flows in the past. Any repeat of this in the future could adversely affect the company’s business.

Clinitech Lab Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Clinitech Lab IPO

Apply asPrice bandApply Range
Regular96 - 96₹2 - 5 Lakh
High Networth Individual96 - 96₹2 - 5 Lakh
For Clinitech Lab IPO, eligible investors can apply as Regular.